CELLUREON is a Panama-based biotechnology company specializing in the development and commercialization of ethically sourced, high-performance cell-based and cell-free regenerative therapies.
Our proprietary Wharton’s Jelly MSCs (WJ-MSCs) and their acellular derivatives are produced using advanced technologies including TFF, SEC, and NTA to guarantee consistent quality, safety, and potency.
Backed by a team with over 15 years of regenerative medicine experience, CELLUREON is setting a new standard in therapeutic biologics for orthopedics, neurology, aesthetics, and chronic inflammatory conditions.

Usamos cookies para analizar el tráfico del sitio web y optimizar tu experiencia en el sitio. Al aceptar nuestro uso de cookies, tus datos se agruparán con los datos de todos los demás usuarios.